Endometrioid Stromal Sarcoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Endometrioid Stromal Sarcoma

subtype

Identifier: CI-CAN-00002589
Entity page: /cancer/endometrioid-stromal-sarcoma ↗
Edges: 17

Neighbours: 6 drugs10 trials
Drawn: 16 of 16 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Endometrioid Stromal Sarcoma investigated for …INVESTIGATED_FOR1 of 1
← investigated for	Fulvestrantsmall_molecule	unknown	2	Endometrioid Stromal Sarcoma	1	Curated	chembl	graph →
Endometrioid Stromal Sarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived6 of 6

Endometrioid Stromal Sarcoma studied in …STUDIED_INderived10 of 10
→ studied in	NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03624244Phase 2 · recruiting Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Low Grade Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04811196Phase 1 · completed A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03241745Phase 2 · completed A Study of Nivolumab in Selected Uterine Cancer Patients · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	High-Grade Endometrial Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03926936Phase 2 · completed FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01210222Phase 2 · completed Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02150213Phase 2 · completed Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Endometrioid Stromal Sarcoma	1	Observed	clinicaltrials	graph →